Back to Amova Asset Management Americas, Inc. Amova Asset Management Americas, Inc.

NTLANTLA

Showing 8 of 30 quarters

Position history for Amova Asset Management Americas, Inc.Amova Asset Management Americas, Inc.'s holdings in Intellia Therapeutics, Inc.

Yes. Amova Asset Management Americas holds 2,897,529 shares of NTLA (Intellia Therapeutics), worth $49M, as of its Q2 2026 13F filing. It increased the position by 924,468 shares (+46.9%) from Q1 2026. Amova Asset Management Americas has held NTLA in every 13F on record since Q1 2019, 30 quarterly filings. NTLA is 0.6% of Amova Asset Management Americas' reported 13F portfolio.

Current Value

$49M

Current Shares

2.9M

Total Value Change

-$15.6M

Total Shares Change

-250,868

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.9M
+46.9%
$49M0.6%$16.92
56
2026-Q1
Decreased
2M
-10.0%
$25.3M0.4%$12.82
0
2025-Q4
Decreased
2.2M
-6.9%
$19.7M0.2%$8.99
0
2025-Q3
Decreased
2.4M
-11.8%
$40.6M0.4%$17.27
0
2025-Q2
Decreased
2.7M
-5.5%
$25M0.2%$9.38
0
2025-Q1
Decreased
2.8M
-5.6%
$20M0.3%$7.11
0
2024-Q4
Decreased
3M
-5.0%
$34.9M0.4%$11.66
0
2024-Q3
Decreased
3.1M
-3.4%
$64.7M0.7%$20.55
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used